During the recent session, Exact Sciences Corp. (NASDAQ:EXAS)’s traded shares were 0.71 million, with the beta value of the company hitting 1.24. At the last check today, the stock’s price was $58.97, reflecting an intraday loss of -6.75% or -$4.27. The 52-week high for the EXAS share is $100.77, that puts it down -70.88 from that peak though still a striking 4.95% gain since the share price plummeted to a 52-week low of $56.05. The company’s market capitalization is $10.70B, and the average trade volume was 2.44 million shares over the past three months.
Exact Sciences Corp. (NASDAQ:EXAS) trade information
Exact Sciences Corp. (EXAS) registered a -6.75% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -6.75% in intraday trading to $58.97, hitting a weekly high. The stock’s 5-day price performance is -7.10%, and it has moved by -9.61% in 30 days. Based on these gigs, the overall price performance for the year is -7.21%.
Exact Sciences Corp. (EXAS) estimates and forecasts
Statistics show that Exact Sciences Corp. has outperformed its competitors in share price, compared to the industry in which it operates. Exact Sciences Corp. (EXAS) shares have gone down -10.32% during the last six months, with a year-to-date growth rate more than the industry average at 23.89% against 12.90. In the rating firms’ projections, revenue will increase 13.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 627.36M as predicted by 20 analyst(s). Meanwhile, a consensus of 20 analyst(s) estimates revenue growth to 700.15M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 602.45M and 622.09M respectively. In this case, analysts expect current quarter sales to grow by 4.10% and then jump by 12.50% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 4.59%. While earnings are projected to return 19.50% in 2024.
EXAS Dividends
Exact Sciences Corp. is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
